Tirzepatide (Mounjaro) 10mg

Tirzepatide (Mounjaro) 10mg

Tirzepatide 10mg is a dual incretin receptor agonist used in clinical settings for glycemic control and metabolic regulation. It is the active ingredient in Mounjaro, a prescription medication widely used in the management of type 2 diabetes and studied for weight-related metabolic outcomes.

🔬 Key Benefits (Clinical Context)

• Helps improve blood glucose control (type 2 diabetes)
• Supports appetite regulation and reduced caloric intake
• Enhances insulin sensitivity and metabolic function
• Studied for effects on body weight management

⚙️ Mechanism of Action

Tirzepatide works by activating two key incretin receptors:

• GIP (glucose-dependent insulinotropic polypeptide)
• GLP-1 (glucagon-like peptide-1)

This results in:

• Increased glucose-dependent insulin secretion
• Reduced glucagon release
• Slower gastric emptying
• Increased satiety and appetite suppression

🧬 Product Details

• Active ingredient: Tirzepatide
• Strength: 10 mg
• Class: Dual GIP/GLP-1 receptor agonist
• Form: Injectable prescription formulation
• Primary use: Metabolic and glycemic control